These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11270185)

  • 21. Complete congenital heart block: risk of occurrence and therapeutic approach to prevention.
    Buyon J; Roubey R; Swersky S; Pompeo L; Parke A; Baxi L; Winchester R
    J Rheumatol; 1988 Jul; 15(7):1104-8. PubMed ID: 3262756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.
    Costedoat-Chalumeau N; Amoura Z; Lupoglazoff JM; Huong DL; Denjoy I; Vauthier D; Sebbouh D; Fain O; Georgin-Lavialle S; Ghillani P; Musset L; Wechsler B; Duhaut P; Piette JC
    Arthritis Rheum; 2004 Oct; 50(10):3187-94. PubMed ID: 15476223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of infants from mothers with anti-SSA/Ro antibodies.
    Motta M; Rodriguez-Perez C; Tincani A; Lojacono A; Chirico G
    J Perinatol; 2007 May; 27(5):278-83. PubMed ID: 17363909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies.
    Gladman G; Silverman ED; Yuk-Law ; Luy L; Boutin C; Laskin C; Smallhorn JF
    Am J Perinatol; 2002 Feb; 19(2):73-80. PubMed ID: 11938480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Congenital complete atrioventricular block in children: pathogenesis and clinical outcomes].
    Udink ten Cate FE; Breur JM; van Woerkom JM; Kruize AA; Stoutenbeek P; Meijboom EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(38):1777-81. PubMed ID: 12369438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital heart block: Pace earlier (Childhood) than later (Adulthood).
    Manolis AA; Manolis TA; Melita H; Manolis AS
    Trends Cardiovasc Med; 2020 Jul; 30(5):275-286. PubMed ID: 31262557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.
    Friedman DM; Kim MY; Copel JA; Davis C; Phoon CK; Glickstein JS; Buyon JP;
    Circulation; 2008 Jan; 117(4):485-93. PubMed ID: 18195175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had QT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth.
    Cimaz R; Meroni PL; Brucato A; Fesstovà V; Panzeri P; Goulene K; Stramba-Badiale M
    Arthritis Rheum; 2003 Jan; 48(1):266-8. PubMed ID: 12528128
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic plasmapheresis for the prevention of congenital complete heart block associated with anti-SS-A/Ro antibody and anti-SS-B/La antibody].
    Miyakata S; Takeuchi K; Yamaji K; Kanai Y; Tsuda H; Takasaki Y
    Ryumachi; 2001 Aug; 41(4):726-35. PubMed ID: 11577401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block.
    Franceschini F; Brucato A; Quinzanini M; Calzavara-Pinton PG; Coluccio E; Cavazzana I; Cattaneo R
    Clin Exp Rheumatol; 1999; 17(5):634-5. PubMed ID: 10544858
    [No Abstract]   [Full Text] [Related]  

  • 32. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
    Clancy RM; Buyon JP
    Rheum Dis Clin North Am; 2004 Aug; 30(3):589-602, x. PubMed ID: 15261343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal lupus erythematosus. Report of serological and immunogenetic studies in twins discordant for congenital heart block.
    Watson RM; Scheel JN; Petri M; Kan JS; Provost TT; Ratrie H; Callan NA
    Br J Dermatol; 1994 Mar; 130(3):342-8. PubMed ID: 8148276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody mediated complete congenital heart block in the fetus.
    Olah KS; Gee H
    Pacing Clin Electrophysiol; 1993 Sep; 16(9):1872-9. PubMed ID: 7692420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent fetal sinus bradycardia associated with maternal anti-SSA/Ro and anti-SSB/La antibodies.
    Chockalingam P; Jaeggi ET; Rammeloo LA; Haak MC; Adama van Scheltema PN; Breur JM; Bartelings MM; Clur SA; Blom NA
    J Rheumatol; 2011 Dec; 38(12):2682-5. PubMed ID: 22089457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feto-maternal outcome in pregnancies complicated by isolated fetal congenital complete heart block.
    Roy KK; Subbaiah M; Kumar S; Sharma JB; Singh N
    J Obstet Gynaecol; 2014 Aug; 34(6):492-4. PubMed ID: 24830484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Ro (SS-A) antibodies and congenital complete heart block.
    McNeil P; Edmonds J
    Aust N Z J Med; 1985 Dec; 15(6):767-8. PubMed ID: 3914881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infants born to mothers with anti-SSA/Ro autoantibodies: neonatal outcome and follow-up.
    Zuppa AA; Fracchiolla A; Cota F; Gallini F; Savarese I; D'Andrea V; Luciano R; Romagnoli C
    Clin Pediatr (Phila); 2008 Apr; 47(3):231-6. PubMed ID: 18057159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrops fetalis with complete heart block secondary to congenital lupus: report of one case.
    Hung CL; Lin CH; Mu SC; Sung TC
    Acta Paediatr Taiwan; 1999; 40(4):265-7. PubMed ID: 10910626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.